Academic Journals Database
Disseminating quality controlled scientific knowledge

Ocular Drug Delivery for Glaucoma Management

ADD TO MY LIST
 
Author(s): Nathan Gooch | Sarah A. Molokhia | Russell Condie | Randon Michael Burr | Bonnie Archer | Balamurali K. Ambati | Barbara Wirostko

Journal: Pharmaceutics
ISSN 1999-4923

Volume: 4;
Issue: 1;
Start page: 197;
Date: 2012;
Original page

Keywords: glaucoma | IOP | drug delivery | sustained release | polymer | inserts | punctal plug

ABSTRACT
Current glaucoma management modalities are hindered by low patient compliance and adherence. This can be due to highly complex treatment strategies or poor patient understanding. Treatments focus on the management or reduction of intraocular pressure. This is most commonly done through the use of daily topical eye drops. Unfortunately, despite effective therapies, glaucoma continues to progress, possibly due to patients not adhering to their treatments. In order to mitigate these patient compliance issues, many sustained release treatments are being researched and are entering the clinic. Conjunctival, subconjunctival, and intravitreal inserts, punctal plugs, and drug depots are currently in clinical development. Each delivery system has hurdles, yet shows promise and could potentially mitigate the current problems associated with poor patient compliance.
Affiliate Program      Why do you need a reservation system?